Latest Market Strategy News

Page 12 of 33
PainChek has secured FDA-regulated medical device status, enabling US Remote Therapeutic Monitoring reimbursement and opening a major US growth avenue. The company targets musculoskeletal pain management in non-verbal dementia patients, a largely underserved market.
Ada Torres
Ada Torres
29 Jan 2026
Lotus Resources has made significant progress resolving sulphuric acid supply issues critical to ramping up production at its Kayelekera Uranium Mine, though full steady-state output is now expected in the second quarter of 2026.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Canadian Phosphate Limited has improved its operating cash flow and strengthened its balance sheet through a successful capital raise and asset sale, while advancing key permits and strategic partnerships for its Canadian phosphate projects.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Excite Technology Services has reported a record-breaking quarter with $9.2 million in customer receipts, marking a 125% increase year-over-year, alongside positive operating cash flow and strategic contract wins.
Sophie Babbage
Sophie Babbage
22 Jan 2026
Lynas Rare Earths reported a 43% year-on-year revenue increase to A$201.9 million in Q2 FY26 despite a 30% drop in key NdPr production due to power disruptions and maintenance. The company also announced CEO Amanda Lacaze’s planned retirement at year-end.
Maxwell Dee
Maxwell Dee
21 Jan 2026
SportsHero Limited has reported its highest quarterly cash receipts since listing, driven by a milestone payment from its Philippines launch and rapid subscriber growth for its HeroPlay platform in Indonesia.
Sophie Babbage
Sophie Babbage
19 Jan 2026
Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.
Sophie Babbage
Sophie Babbage
14 Jan 2026
Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.
Ada Torres
Ada Torres
30 Dec 2025
Nutritional Growth Solutions announces the departure of CEO Stephen J. Turner, appointing Non-Executive Director Andrew Grover as interim CEO to steer the company through its next phase.
Ada Torres
Ada Torres
24 Dec 2025
Fenix Resources’ latest Scoping Study outlines a robust plan to ramp up Weld Range iron ore production to 10 million tonnes per annum by 2031, extending mine life to 2042 with significantly reduced costs and strong financial returns.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Blue Star Helium has successfully started helium production at its Pinon Canyon plant, marking a key milestone as it prepares for commercial sales and expansion in 2026.
Maxwell Dee
Maxwell Dee
22 Dec 2025
Swift TV Ltd has ceased its decade-long monthly subscription services with Mineral Resources, pivoting to a hardware-enabled SaaS model with its flagship Swift TV product. The company is set to deploy over 4,300 screens across 11 sites by March 2026, marking a significant strategic shift.
Sophie Babbage
Sophie Babbage
19 Dec 2025

Browse the archive

Full archive